Genomate Health, a leader in revolutionizing cancer care through precision oncology, is thrilled to announce its participation in the prestigious Precision Medicine World Conference (PMWC) 2024, unfolding in Silicon Valley from January 24th to 26th.

On January 24th, the visionary Istvan Petak, MD, PhD, CEO of Genomate Health, will take the stage on Showcase Track S1, to share groundbreaking insights on "AI and Data Sciences Showcase: Genomate Health Inc". This session promises an immersive dive into Genomate's contributions to AI-driven precision oncology. As we stand at the cusp of a new era in healthcare, this talk isn't just about Genomate Health; it's about the future of cancer care. Dr. Petak's insights will provide a glimpse into a world where personalized solutions offer hope to patients, where AI becomes a cornerstone in informed decision-making, and where the quality of life for cancer patients is significantly enhanced.

Talk Details:

• Date: January 24, 2024
• Presentation: AI and Data Sciences Showcase: Genomate Health Inc
• Presenter: Istvan Petak, MD, PhD, CEO of Genomate Health Inc
• Track: Showcase Track S1

This is a unique opportunity to witness firsthand the future of cancer care. Genomate Health flagship product, Genomate, is at the forefront of precision oncology, leveraging artificial intelligence and genomic insights to reshape cancer treatment. Genomate's computational reasoning AI model automatically matches treatment options to the combinations of the co-occurring 4-5 genetic driver alterations and biomarkers present in each tumor (on average) instead of linking therapies to individual biomarkers one by one.

Join the Genomate Health team at PMWC 2024 and explore the potential of AI in personalized medicine. For more information about the PMWC 2024 program and to register for the event, please visit PMWC 2024 Program. 

‍

For more details about Genomate, 1:1 meetings, or interviews with Istvan Petak, MD, PhD, reach out to our team.

‍

About PMWC 2024

PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
Since 2009, recognized as a vital cornerstone for all constituents of the health care and biotechnology community, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology), in clinical implementation (e.g. cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.

Location:

Silicon Valley - Santa Clara Convention Center

5001 Great America Pkwy

Santa Clara, CA 95054

‍

About Genomate Health

Genomate Health Inc. is a digital health company (based in Cambridge, MA) that develops AI-powered computational tools for personalized medicine. Its main focus is assisting physicians in making optimal personalized treatment decisions for each patient based on the complex molecular characteristics of human diseases.

Its flagship product, Genomate® MTC (Molecular Treatment Calculator), is a powerful computational (open box AI) tool aiming to optimize treatment decision-making in precision oncology by automated data compilation, evaluation, and synthesis in a knowledge model allowing standardized, personalized treatment decisions based on the totality of available molecular information. The company’s goal is to make this solution globally available to cancer patients and their oncologists in 2023. For more information, visit www.genomate.health, and follow the momentum on Facebook, Twitter, Instagram, and LinkedIn.

‍

Media Inquiries:

Alina Luchian

Brand Manager, Genomate Health Inc

alina.luchian(at)genomate.health